Shanghai RAAS(002252) 证券之星·2025-03-26 14:19Core Viewpoint - Shanghai Laishi Blood Products Co., Ltd. held its ninth (temporary) meeting of the sixth board of directors on March 25, 2025, where significant resolutions were made regarding acquisitions and bank loans [1][2]. Group 1: Meeting Details - The meeting was convened by the chairwoman, Ms. Tan Lixia, and all nine directors attended, ensuring compliance with the Company Law and the company's articles of association [1]. - The meeting allowed all directors to express their opinions fully before voting [1]. Group 2: Resolutions Passed - A unanimous decision was made to approve the acquisition of equity in Nanyue Biopharmaceutical Co., Ltd., with a voting result of 9 votes in favor, 0 against, and 0 abstentions [1]. - The board also approved an announcement regarding the application for a bank merger loan, with the same voting results [2].